InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Schorno Dean L, Chief Financial Officer. Officer active across 1 companies, notably RIGEL PHARMACEUTICALS INC. In total, 2 filings have been published. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
050,000 shares0
Common Stock
SEC:0001567619-22-001782·
050,000 shares0
Common Stock
SEC:0001567619-22-001782:0·
2 of 2 declarations
About Schorno Dean L
Dean L. Schorno is the Executive Vice President and Chief Financial Officer of Rigel Pharmaceuticals Inc. In this role, he oversees the company's financial operations, including cash management and financial reporting. With expertise in the pharmaceutical sector, he contributes to the financial strategy of Rigel Pharmaceuticals, which develops treatments for serious diseases.
